BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21292307)

  • 1. Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays.
    Ananthanarayanan V; Deaton RJ; Amatya A; Macias V; Luther E; Kajdacsy-Balla A; Gann PH
    Hum Pathol; 2011 Jun; 42(6):873-81. PubMed ID: 21292307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
    Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
    Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
    Watson NF; Durrant LG; Scholefield JH; Madjd Z; Scrimgeour D; Spendlove I; Ellis IO; Patel PM
    World J Gastroenterol; 2006 Oct; 12(39):6299-304. PubMed ID: 17072952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
    Cote RJ; Shi Y; Groshen S; Feng AC; Cordon-Cardo C; Skinner D; Lieskovosky G
    J Natl Cancer Inst; 1998 Jun; 90(12):916-20. PubMed ID: 9637141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
    Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
    Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.
    Rizzardi AE; Zhang X; Vogel RI; Kolb S; Geybels MS; Leung YK; Henriksen JC; Ho SM; Kwak J; Stanford JL; Schmechel SC
    Diagn Pathol; 2016 Jul; 11(1):63. PubMed ID: 27401406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.
    Vlachostergios PJ; Karasavvidou F; Kakkas G; Kapatou K; Gioulbasanis I; Daliani DD; Moutzouris G; Papandreou CN
    J Negat Results Biomed; 2012 Jan; 11(1):2. PubMed ID: 22221586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
    Ansong E; Ying Q; Ekoue DN; Deaton R; Hall AR; Kajdacsy-Balla A; Yang W; Gann PH; Diamond AM
    PLoS One; 2015; 10(5):e0127295. PubMed ID: 25993660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p21(waf1/cip1), p27 (kip1), p63 and androgen receptor in low and high Gleason score prostate cancer.
    Romics I; Bánfi G; Székely E; Krenács T; Szende B
    Pathol Oncol Res; 2008 Sep; 14(3):307-11. PubMed ID: 18415709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy.
    Izumi K; Li Y; Zheng Y; Gordetsky J; Yao JL; Miyamoto H
    Hum Pathol; 2012 Nov; 43(11):1991-2000. PubMed ID: 22617231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
    Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
    Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
    Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
    J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
    Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer.
    Halvorsen OJ; Haukaas SA; Akslen LA
    Clin Cancer Res; 2003 Apr; 9(4):1474-9. PubMed ID: 12684422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
    Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
    Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.